Novocure is a medical technology company based in Pennsylvania that develops cancer treatment devices. Its recent lobbying focused on trade and tariff policy, including matters tied to Section 301 investigations (U.S. trade actions on unfair foreign practices), and on medical research and clinical lab issues. The firm reported $30,000 in lobbying across two filings and used Mayer Brown LLP to represent it.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DANIEL HARDER
The latest disclosures for this client.
MAYER BROWN LLP
Q4MAYER BROWN LLP
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MAYER BROWN LLP
WARREN PAYNE
MAYER BROWN LLP